Navigation Links
VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
Date:5/15/2008

- Top Line Data Expected soon after CEA Trial data reports in third quarter

-

SAN FRANCISCO, May 15 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it has completed patient enrollment in its acute coronary syndrome (ACS) study. The ACS study is one of three Phase 2 trials investigating VIA-2291, the company's lead product candidate in cardiovascular disease.

VIA-2291 is a potent small molecule drug that targets inflammation in the blood vessel wall, a primary disease process in atherosclerosis. It is being developed as a once-daily, oral drug to potentially decrease the risk of major adverse cardiac events (MACE) associated with inflammation, including heart attack and stroke.

"Completing enrollment in our second Phase 2 study is an important milestone for the company, and also represents the largest number of patients we have enrolled in a clinical trial to date," said Lawrence K. Cohen, PhD, chief executive officer of VIA Pharmaceuticals. "This trial will provide important data on VIA-2291's effect in the target population, patients with recent heart attack or unstable angina, and we remain on track to deliver data from this key trial later this year."

The ACS study, which enrolled 191 patients, is designed to establish dose and safety data in patients with ACS who have experienced a recent heart attack or unstable angina. The study includes measures of leukotrienes, biomarkers of inflammation, as well as medical imaging of the coronary vessels to evaluate the impact on plaque characteristics in a subset of patients. Patients i
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015  CytomX, a biopharmaceutical company developing ... announced the promotion of several members of its ... who previously served as vice president of business ... senior vice president of corporate development and strategy. ... as the vice president of business development at ...
(Date:8/3/2015)... 3, 2015 Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: ... Daniel Teper , will present live at VirtualInvestorConferences.com on ... TIME:   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... event where investors are invited to ask the company ... as well as the association,s "virtual trade booth." If ...
(Date:8/3/2015)... 2015 Shire plc (LSE: ... it has acquired New York ... million. With the acquisition, Shire acquires the global ... povidone iodine (PVP-I) and 0.1% dexamethasone), a therapy ... conjunctivitis, an ocular surface condition commonly referred to ...
Breaking Medicine Technology:CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6
... Pharmaceuticals, Inc. (NASDAQ: IDIX ), a biopharmaceutical company ... treatment of human viral diseases, today announced that it has ... common stock. All of these shares are being sold by ... as sole book-running manager and underwriter for the offering. Idenix ...
... 7, 2011 MinuteClinic, the retail health ... ), has entered into a clinical affiliation with Advocate ... high quality, affordable health care services provided to patients ... the largest clinical collaboration between a regional health system ...
Cached Medicine Technology:Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock 2New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 2New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 3New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 4
(Date:8/3/2015)... ... 03, 2015 , ... Cambia Health Solutions has promoted Scott ... company’s Medicare and Federal Employee Programs (FEP) lines of business. , Government ... members. In this role, Scott is responsible for overseeing the growth, finance and ...
(Date:8/3/2015)... ... August 03, 2015 , ... The American Institute of ... agreement to collaborate across a wide range of initiatives ranging from code development ... architects. , “Our combined membership, consisting of practicing design professionals, code officials, and ...
(Date:8/2/2015)... , ... August 03, 2015 , ... ... will be attending and exhibiting at the Association for Healthcare Documentation Integrity’s (AHDI) ... , “We are pleased for the opportunity the AHDI conference provides us to ...
(Date:8/2/2015)... Michigan (PRWEB) , ... August ... ... (POP) results when the supportive muscles and connective tissues of a woman’s ... this weakness and damage include straining, heavy lifting, obesity, constipation, multiple vaginal ...
(Date:8/1/2015)... ... August 02, 2015 , ... Back packs can be dangerous? Whaaat?! , ... packs can wreck havoc on a kid's spine. With school starting again, most kids ... school. Make sure you are aware of how to help them prevent injuries by ...
Breaking Medicine News(10 mins):Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2
... , , ... , , ATLANTA, Sept. 11 Atlanta-based indoor ... as the only laboratory in the United States to perform office ... is the oldest and most respected eco-label in the world. ...
... Sept. 11 Corgenix Medical Corporation (OTC Bulletin Board: CONX), a ... conference call on Friday, September 25, 2009, at 4:00 PM EDT ... year ended June 30, 2009, and the status of the Company,s ... Corgenix invites all those interested in hearing management,s discussion of the ...
... alone doesn,t measure severity of cases, researchers say , FRIDAY, ... value of hospital report cards and national rankings when it ... Health System in Chicago say the mortality index, a statistic ... a given area of medical care, may be inflated -- ...
... infection tends to strike young adults, expert says , ... has been focused on getting vaccinated for both the ... nationwide effort has been launched to highlight the need ... sometimes deadly infection that tends to strike teenagers and ...
... ... at the lowest prices possible. To maintain high quality standards and ensure consumer trust, ... of product safety and efficacy. , ... Fargo, ND (Vocus) September 11, 2009 -- Last month ConsumerLab.com (CL), ...
... , , , , ... of Celebratory Events , , VALHALLA, N.Y., ... the advanced care pediatric facility serving New York,s Hudson Valley region ... September and will commemorate the milestone with a year-long series of ...
Cached Medicine News:Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 2Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 3Health News:Report Cards for Hospitals May Be Misleading 2Health News:Actress Helps Promote New Campaign for Meningitis Vaccine 2Health News:Actress Helps Promote New Campaign for Meningitis Vaccine 3Health News:Swanson Health Products' Vitamin E and Acai Dietary Supplements Pass Quality Control Tests Conducted by ConsumerLab.com 2Health News:Celebrating Five Years of Advanced Care Excellence: Maria Fareri Children's Hospital at Westchester Medical Center Reaches a Milestone 2Health News:Celebrating Five Years of Advanced Care Excellence: Maria Fareri Children's Hospital at Westchester Medical Center Reaches a Milestone 3
... PDC Smart™ Labels have a direct ... Texas Instruments Tag-it™ HF-I transponder. When ... codes, text and other graphics may ... variable data is programmed to the ...
... pending solution using Radio Frequency Identification ... label to promote patient safety by ... surgery. This simple to use system ... with the operating room staff in ...
... facilities, recreational venues and more can ... automated data capture that boosts efficiency ... dangerous errors. RFID wristbands can also ... entertainment venues as well as be ...
... The optional Kisses component ... designed to assist nursing staff ... mothers while in the hospital. ... you have an easy, effective ...
Medicine Products: